Roche entered into a $1.15 billion licensing agreement with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta's investigational gene therapy for Duchenne muscular dystrophy (DMD) outside the United States.
from Reuters: Business News https://ift.tt/374Y9B8
Sunday, December 22, 2019
Home »
business news
,
latest business news
» Roche enters $1.15 billion licensing deal for Sarepta gene therapy
Roche enters $1.15 billion licensing deal for Sarepta gene therapy
Banks must refund fraud up to £85,000 in five days
Victims tricked into sending money to scammers must be refunded within five days under new rules. from BBC News https://ift.tt/BQfFbAH
0 comments:
Post a Comment